Albany, NY -- (SBWIRE) -- 12/31/2018 -- The global market for multiplex arrays is prognosticated to witness a strong demand during the forecast period 2018 – 2026, owing to rapid technological advancement leading to impressive progress in nanoscience. Strategic collaboration of major players to expand their customer base and increase their product portfolio is predicted to favor the market growth, notice ResearchMoz.us. In a 333 pages report titled, "Multiplex Assays Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018 – 2026", the analysts provides in-depth analysis of the market thus helping readers to comprehend with market complicacies. The report also provides numerous important factors such as drivers, trends, restraints, and opportunities, which are likely to have tremendous impact on the market growth. The report also provides company profiles of major players in the market.
Significant technological advancement is considered to be one of the major factors pushing the market in the forward direction. Growing awareness about multifactorial nature of pathological conditions and several diseases like Alzheimer's disease and cancer have increased the demand for cost-effective, time saving, and simultaneous measurement of multiple analytes in a single sample.
Get a Sample PDF: https://www.researchmoz.us/enquiry.php?type=S&repid=1950987
This is expected to have a positive influence on the market. Extensive rise in research and development activities in the life sciences have proved to be a boon for the market. However, need for high investment and time to optimize multiple assays for new application safely is considered to bring down the market growth. Furthermore, complex clinical trial procedure and reproducibility crisis for multiplex assay products are anticipated to deter market growth. Nonetheless, funds provided by government to encourage research and development activities is envisaged to help market reach new heights.
The global multiplex assays market is classified on the basis of technology, type, product, application, end user and region. On the basis of type, the market is divided into protein, planar, nucleic acid, bead-based, bread-based, and cell. The market finds its application in cancer, neuro-endocrine diseases, cardiovascular diseases, biomarker research and application, drug discover and research, research and development, infectious diseases, autoimmune diseases, and others. Based on the end user, the market is segregated into hospitals, biotechnology and biopharmaceutical companies, diagnostics centers, academic and research centers, and others. On the basis of technology the market is classified into luminescence, flow cytometry, Mutliplex RT-PCR, fluorescence, and others.
Geographically, the market is divided into North America, Asia Pacific, Latin America, Middle East and Africa, and Europe. Amongst the pack, North America is likely to continue holding the leading position owing to high research and development activities in the region. Apart from these, presence of well-established players in the region is likely to favor market growth. However, on the other hand, Asia Pacific is expected to exhibit a steady growth owing to impressive contribution from India and China. Some of the major players in the market are Merck KGaA, Illumina, Inc., QIAGN N.V., Bio-Rad laboratories, Inc., and Luminex Corporation.
Contact Us:
Mr. Nachiket
Albany NY - 12207
United States
Tel: +1-518-621-2074
Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG